Psychedelic Society
- psychedelicmentalhealth.net Neural correlates and subjective experiences in meditation vs psychedelics, including ketamine (Preliminary Lit Review)
A preliminary, evolving review of the literature. (Ongoing Draft) | Psychedelic Institute of Mental Health & Family Therapy
-
Ketamine is a psychedelic medicine that is most associated with descriptions of a near death experience
psychedelicmentalhealth.net Psychedelic Institute of Mental Health & Family TherapyPsychedelic Therapy, Research, News, Professional Development | Ketamine Telehealth CA, CO, MI, NC, NY, OR, UT, VT
-
Psychedelic Cognitive Behavioral Therapy (Part 2: On Ketamine, Context and Competencies in "Assisted-Psychotherapy")
psychedelicmentalhealth.net Psychedelic Cognitive Behavioral Therapy: On Ketamine, Context and Competencies in "Assisted-Psychotherapy”There are many tools to help a psychotherapist help clients learn to speak the language of cognitive behavioral therapy, especially tools which may help facilitate therapeutic alliance, including, but not limited to telehealth.
- flip.it Some psychedelic medicine developers want to ditch the therapy aspect. What could go wrong?
Are drugs like psilocybin and MDMA still safe and effective in the absence of psychotherapy?
- psychedelic-institute-of-mental-health.ghost.io Does the "psychedelic experience" matter?
Part 3 Psychedelic as experience that when experienced, seems to help people profoundly more often than it harms people irreparably Although working on many different parts and systems in the brain, some overlapping with serotonergic psychedelics, some not, the experience and its effects have be...
-
At-home, telehealth-supported ketamine treatment for depression: Findings from longitudinal, machine learning and symptom network analysis of real-world data (Mathai, et al, 2024)
toad.social PlanetMedicines (@[email protected])https://psychedelictherapy.institute/ketamine-research-1/at-home-ketamine-therapy At-home, telehealth-supported ketamine treatment for depression: Findings from longitudinal, machine learning and symptom network analysis of real-world data (Mathai, et al, 2024) #ketamine #psychedelics #psychedelicre...
-
California Kills Psychedelic Bill: The Regulated Psychedelic Facilitators Act and the Regulated Psychedelic-Assisted Therapy Act
cross-posted from: https://lemmy.world/post/15128774
> Bill killed May 16th https://www.yahoo.com/news/california-lawmakers-kill-psychedelics-legalization-220852017.html
-
Event: June 27, 2024– FDA hosts “Understanding Current Use of Ketamine for Emerging Areas of Therapeutic Interest”
reaganudall.org Understanding Current Use of Ketamine for Emerging Areas of Therapeutic Interest | Reagan-Udall FoundationThe Reagan-Udall Foundation for the FDA, in collaboration with the FDA, is hosting a hybrid public workshop on "Understanding Current Use of Ketamine for Emerging Areas of Therapeutic Interest."
-
International Ketamine Conference in Oxford debates ketamine at home, with majority agreeing at home ketamine is safe, when addressing risks
toad.social PlanetMedicines (@[email protected])Attached: 1 image #ketamine At home ketamine can be safe. Working with a licensed psychotherapist through a course of ketamine-assisted psychotherapy is one way to decrease risk. (2024) https://www.biospace.com/article/opinion-can-ketamine-be-safely-used-at-home-/ #psychedelics #psychedelicresearch...
-
New study on adverse childhood experiences and ayahausca
flip.it Is childhood trauma linked to challenging ayahuasca experiences? New study has surprising answerA recent study found no link between trauma history and the severity of psychedelic challenges or subsequent psychological growth, suggesting individual reactions to ayahuasca are highly variable.
“… experiencing challenges during ayahuasca sessions was not significantly correlated with any long-term psychological benefits. This suggests that the difficulties encountered during these sessions do not inherently result in personal development or improvement in psychological well-being, which contrasts with some anecdotal claims and previous smaller-scale studies suggesting that overcoming psychedelic-induced challenges could foster significant personal insights and growth.”
-
Event: April 30th, Q&A with psychedelic researcher Rick Strassman, MD
Join us for an insightful Q&A session with Dr. Rick Strassman! With a rich background in both clinical psychiatry and groundbreaking research in psychedelic substances, Dr. Strassman brings a unique perspective to the intersection of medicine, spirituality, and consciousness. Gain a deeper understanding of Dr. Strassman’s pioneering research with psychedelic substances, its impact on the scientific community, and its implications for the future of mental health treatment. Explore the therapeutic potential of psychedelic substances in the field of psychiatry, including their applications in treating mental health disorders and enhancing psychotherapy. Discover the diverse literary works of Dr. Strassman, spanning from non-fiction explorations of psychedelics to fictional narratives and personal reflections on altered states of consciousness.
Whether you’re a healthcare professional, researcher, student, or simply curious about the mysteries of the mind, this event promises to be both informative and inspiring. Reserve your spot now for an evening of insightful discussion and intellectual exploration. Register- https://donate.stripe.com/aEU15w02Gf7N7EAeVt
-
The therapeutic alliance between study participants and intervention facilitators is associated with acute effects and clinical outcomes in a psilocybin-assisted therapy trial (Levin, et al, 2024)
journals.plos.org The therapeutic alliance between study participants and intervention facilitators is associated with acute effects and clinical outcomes in a psilocybin-assisted therapy trial for major depressive disorderWe examined if the therapeutic alliance between study participants and intervention facilitators in a psilocybin-assisted therapy (PAT) trial changed over time and whether there were relationships between alliance, acute psilocybin experiences, and depression outcomes. In a randomized, waiting list-...
cross-posted from: https://lemmy.world/post/14608342
> Psychedelic medicines have been studied as an adjunct to psychotherapy for over 100 years.
-
As California Seeks to Legalize Psychedelics for Therapy, Oregon Provides Key Lessons (2024)
www.kqed.org As California Seeks to Legalize Psychedelics for Therapy, Oregon Provides Key Lessons | KQEDFollowing Gov. Gavin Newsom’s veto last year, lawmakers hope SB 1012 can finally regulate supervised use of psychedelics in California.
-
Event: May 3rd webinar— Using Ketamine and EFT to Help Couples in Distress
www.ryanhickstherapy.com Using Ketamine and EFT to Help Couples in Distress — Ryan Hicks Counseling & PsychotherapyEFT shows wonderful outcomes in helping couples in distress. Come hear about how ketamine can be combined with EFT to assist those who just feel stuck in couples therapy.
-
Event: April 16th— Ketamine Assisted Couple Therapy Webinar
www.eventbrite.com Ketamine Assisted Couple Therapy WebinarThis workshop describes a model for ketamine-assisted couple therapy that attendees can use in their own practices.
-
Event— May 7th FREE Webinar: Ketamine Therapy for End of Life Care
www.eventbrite.com FREE Webinar May 7: Ketamine Therapy for End of Life CareKetamine Therapy for End of Life Care: Developing Protocols and Informing Consent in an Emergent Field of Practice
-
April 21 Event- Blue Lotus (DoubleBlind)
DoubleBlind curates some great educational events related to psychedelic and plant medicine topics. Check out the free webinar on Blue Lotus, coming April 21st, 2024.
-
Psychedelic Mystical Experience: A New Agenda for Theology (2022)
www.mdpi.com Psychedelic Mystical Experience: A New Agenda for TheologyWhen the link between psychedelic drugs and mystical states of experience was first discovered in the 1960s, Huston Smith challenged scholars in religion and philosophy to consider the implications. Very few took up his challenge. Beginning in 2006, hundreds of studies have linked psychedelics not j...
-
Event: Psilocybin Therapy for Bipolar Disorder ⏰ Tuesday 16 April, 8PM CET (7PM GMT, 2PM EST, 11AM PST)
open-foundation.org Psilocybin Therapy for Bipolar DisorderResearchers at Maryland University have completed an early phase clinical trial to asses the feasibility and preliminary outcomes of treating Bipolar II Disorder with single-dose synthetic psilocybin. Specifically, this recently published study treated patients with a BD II diagnosis in a current de...
-
The oldest archeological data evidencing the relationship of Homo sapiens with psychoactive plants: A worldwide overview (2019)
toad.social PlanetMedicines (@[email protected])Attached: 1 image The oldest archeological data evidencing the relationship of Homo sapiens with psychoactive plants: A worldwide overview (2019) https://akjournals.com/view/journals/2054/3/2/article-p63.xml #psychedelics #psychedelic #plantmedicine #history
-
California Psychedelic Wellness & Healing Initiative of 2024
www.pw4ca.com Home - Psychedelic Wellness & Healing Initiative of 2024Our Purpose To ensure that Californians have the right to obtain and use Entheogenic Substances for medical, therapeutic and spiritual purposes where the medical and therapeutic use is deemed appropriate and has been recommended by a physician, nurse practitioner, or licensed counseling therapist, w...
- m.youtube.com PT456 – Alexander Beiner – Moloch, Kairos, Extended-State DMT, and the Spider Queen
In this episode, David interviews Alexander Beiner: an Executive Director of Breaking Convention; writer of The Bigger Picture substack; and author of The Bi...
- www.salon.com Ego tripping: Why do psychedelics "enlighten" some people — and make others giant narcissists?
Psychedelics have a reputation for humbling people, but "hallucinogenic elitism" is also common. What gives?
-
Introducing psychedelics to end-of-life mental healthcare (Marks, et al 2023)
www.nature.com Introducing psychedelics to end-of-life mental healthcare - Nature Mental HealthEarly evidence suggests psychedelics could help alleviate end-of-life anxiety and depression. Yet there has been little study or discussion of their integration into hospice and palliative care settings, where patients often have complex comorbidities and medication regimens. The authors discuss rel...
- www.psychedelictherapypalmsprings.com Being no one, being One: The role of ego-dissolution and connectedness in the therapeutic effects of psychedelic experience (Kałużna, et al, 2022) — Psychedelic Therapy Palm Springs
While it is unrealistic to attempt to treat all mental health problems with psychedelic therapy, given the therapeutic potential of ego-dissolution and connectedness, equivalent non-psychedelic experiences could be emphasized in other modes of therapy as well as in daily life.
- psyche.co The therapeutic potential, and addictive lure, of losing yourself | Psyche Ideas
In ketamine therapy and other contexts, dissociation is seen as an unwanted side-effect. But what if there’s more to it?
-
Ayahuasca-induced personal death experiences: prevalence, characteristics, and impact on attitudes toward death, life, and the environment (David, et al 2023)
www.frontiersin.org Frontiers | Ayahuasca-induced personal death experiences: prevalence, characteristics, and impact on attitudes toward death, life, and the environmentIntroduction<p>Despite an emerging understanding regarding the pivotal mechanistic role of subjective experiences that unfold during acut...</p>
- maps.org Integration Station - Multidisciplinary Association for Psychedelic Studies - MAPS
MAPS Integration Station A Journey Beyond the Psychedelic: Embracing Transformation Through Mindful Integration Get the Workbook What is Psychedelic Integration? https://vimeo.com/898203191Integration is an important component of psychedelic healing, and there are many definitions of the practice. I...
- www.marijuanamoment.net Missouri Senators Approve Bill To Legalize Psilocybin Therapy For Veterans - Marijuana Moment
A Missouri Senate committee has approved a Republican-led bill to legalize the medical use of psilocybin by military veterans and fund studies exploring the therapeutic potential of the psychedelic. The Senate Emerging Issues Committee passed the legislation from Sen. Holly Thompson Rehder (R), with...
- finance.yahoo.com SciSparc-Clearmind Partnership Yields Three New International Patent Applications for MDMA, Ibogaine and Ketamine Compounds
TEL AVIV, Israel, Feb. 27, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders and rare diseases of the central nervous system, announced today that as part of i...
-
Try psychedelics. Access transcendence. | James Fadiman
YouTube Video
Click to view this content.
-
Synthetic surprise as the foundation of the #psychedelic experience (De Filippo, et al, 2024)
toad.social PlanetMedicines (@[email protected])Attached: 1 image Synthetic surprise as the foundation of the #psychedelic experience (De Filippo, et al, 2024) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10839673/ #paychedelics #psychedelicresearch #psychedelicexperience
-
Salvia Presentation — Eventbrite, Feb 15th, 2024
www.eventbrite.com Salvia Information SessionJoin somatic salvia guide, Christopher Solomon, for an informative and in-depth lecture about Salvia Divinorum.
- www.marijuanamoment.net Massachusetts Lawmakers Approve Psilocybin Bill To Legalize For 'Therapeutic, Spiritual And Medicinal Purposes' - Marijuana Moment
With a psychedelics legalization initiative pending before lawmakers ahead of a potential vote on the November ballot, a Massachusetts legislative committee has advanced a separate bill that would legalize psilocybin therapy in the commonwealth and set up a framework to license facilitators who woul...
- news.lykospbc.com Lykos Therapeutics Announces FDA Acceptance and Priority Review of New Drug Application for MDMA-Assisted Therapy for PTSD
PDUFA date is August 9, 2024 If approved, this would be the first MDMA-assisted therapy and psychedelic-assisted therapy SAN JOSE, Calif., Feb. 9, 2024 /PRNewswire/ -- Lykos Therapeutics (formerly...